首页> 外国专利> DETERMINING TUMOUR CELL MALIGNANCY BY MEANS OF ENDOGENOUS LECTINS

DETERMINING TUMOUR CELL MALIGNANCY BY MEANS OF ENDOGENOUS LECTINS

机译:内源性凝集素测定肿瘤细胞的恶性程度

摘要

The use of endogenous lectins for the in vitro determination of the presence of malignant cells in a given biological sample is described, wherein said lectins are involved in the phenomena of cell adhesion and/or recognition and have a calcium-independent affinity for a site involving mannose residues on glycan ligands, and are immunologically and/or structurally related to CSL or R1, or fragments of said lectins provided that these fragments retain the affinity of the original lectin for said glycan ligands.
机译:描述了使用内源凝集素体外确定给定生物样品中恶性细胞的存在,其中所述凝集素参与细胞粘附和/或识别现象,并且对涉及以下部位的钙具有非钙依赖性聚糖配体上的甘露糖残基,并且在免疫学和/或结构上与CSL或R1相关,或者是所述凝集素的片段,条件是这些片段保留原始凝集素对所述聚糖配体的亲和力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号